The company Genentech, which produces the anti-cancer drug "Avastin" It announced the discovery of numerous cases of counterfeiting. All of them are documented in the United States, but to find out the manufacturer, to know the volume of counterfeit games and much, especially to trace its geography, has not yet succeeded.
This case has been a working group of the Office of Food and Drug Administration (FDA) with the assistance of representatives of Genentech. They found that the fake party "Avastin" It was imported from abroad. The country gained its firm Quality Specialty Products, which implemented a counterfeit medicines and pharmacies.
Unlike branded drugs, pseudo- "Avastin" does not contain the active substance, that is not helping the fight against cancer. To distinguish the fake from the original may be on the eye. For this purpose it is necessary to carefully examine the packaging drugs.
On the counterfeit does not include the name of the manufacturer - the company Genentech. In addition, the party of corporate anti-cancer drug contains a six-digit number consisting of numbers only. If it found the letter or the number of digits is not correct, before you fake.
For reference:
Action "Avastin" directed to certain components of the tumor or its parameters. Indications for use of the drug:
- Metastatic colorectal cancer,
- Locally recurrent or metastatic breast cancer,
- Common unresectable, metastatic or recurrent non-small cell lung cancer nonsquamous,
- Distribution and / or metastatic renal cell carcinoma,
- Glioblastoma (glioma malignancy grade IV according to WHO classification).
In addition, "Avastin" called the biggest breakthrough in the field Cancer treatment ovary in a generation. It significantly extends the life of patients, turning deadly disease into remission.
This medication is used for treatment cancer chest. However, any significant progress in the fight against this disease, "Avastin" never reached.
Industry News
Go back to the main page
Немає коментарів:
Дописати коментар